article thumbnail

Medicare Drug Cuts Target CVD Meds, Drive Debates

CardiacWire

The White House finally unveiled its negotiated Medicare drug prices , bringing 38%-76% reductions to the first 10 drugs, while drawing mixed industry reactions. Medicare drug price negotiations are one of the highlighted results of 2022’s Inflation Reduction Act, allowing CMS to negotiate drug prices for the very first time.

article thumbnail

How to Get Free or Lower Cost Insulin for Your Medicare and Non-Medicare Patients: Shattering Barriers to Insulin Access

Cardiometabolic Health Congress

After years of pressure from the government and activist groups, we are just beginning to see a trend toward lower, more affordable drug prices, with insulin at the forefront of the conversation. How to Get Insulin for Your Medicare Patients Medicare-lowered insulin costs are automatic and will be available at any in-network pharmacy.

article thumbnail

Trends in direct health care costs among US adults with atherosclerotic cardiovascular disease with and without diabetes

Cardiovascular Diabetology

The costs were direct total health care expenditures (out-of-pocket payments and payments by private insurance, Medicaid, Medicare, and other sources) from various sources (office-based visits, hospital outpatient, emergency room, inpatient hospital, pharmacy, home health care, and other medical expenditures).

article thumbnail

The High Cost of Insulin: Bridging Gaps on the Path to Affordable Care

Cardiometabolic Health Congress

However, increasing government and activist pressure has forced manufacturers to lower insulin costs. The recent price cuts mirror the insulin caps for Medicare enrollees that took effect last year as part of President Biden’s Inflation Reduction Act.